Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
adalimumab, advantage, amendment, AMO, anticipated, ARB, asset, assumed, Bayer, benchmark, carrying, chapter, component, comprehensive, conversion, Data, declaratory, decline, demand, demographic, denominated, derecognition, electronically, established, European, expand, eye, facility, FAS, FASB, field, forward, franchise, FSP, functional, guidance, HealthCare, hedge, hedged, Immunochemistry, impairment, indefinite, infant, Interactive, intercompany, Japanese, Jersey, Kaletra, lived, LLC, location, Lupin, Maryland, Matrix, modest, Mylan, negative, niacin, noncontrolling, obligation, ongoing, ophthalmic, percentage, population, post, posted, premier, recent, reclassified, Recognition, repaid, repay, revalued, shown, small, stronger, submit, submitted, suit, surgical, swap, tangible, trade, twelve, unenforceable, variability, variable, Web, yen
Removed:
adjustment, Biaxin, Boston, Canada, consumer, decision, decrease, deferred, discontinued, dividend, exclusion, fourth, fraud, full, Guidant, implemented, integration, intervention, laboratory, letter, marketed, MDL, offer, paid, Point, reduced, retain, revenue, ruling, Scientific, transaction, unfavorably
Filing tables
Filing exhibits
Related press release
ABT similar filings
Filing view
External links
Exhibit 10.10
Abbott Laboratories
Compensation Arrangements
Effective March 1, 2009, the base salary of John M. Capek, Executive Vice President, Medical Devices, is $615,900 and the base salary of Laura J. Schumacher, Executive Vice President, General Counsel and Secretary, is $803,400.